Manual 056 Environmental Monitoring
Manual 056 Environmental Monitoring
1 Purpose
Where required: This Guideline is also applicable to service providers carrying out
work on behalf of sponsor Operations and Research and Development (R&D) when
those activities are covered under GMP and/or ISO standards. It is recognized that it
may not be required to achieve an equivalent level of validation or qualification and
documentation at all phases of the product development process and a sliding scale
towards GMP should be applied. Nonetheless, the extent of validation or qualification
performed shall be sufficient to ensure all research and development products are fit
for their intended purpose. Risk management should be used to maximize potential
opportunities, manage and control uncertainties and minimize potential threats,
particularly risks to the patient. Risk management, when based on scientific and
historical data, provides a means to focus resources on those GMP areas of greatest
need.
3 Definitions
An approach to different levels of approval depending upon the quality class. Ensures
efficiency and flexibility where appropriate to the Phase of development within the
R&D environment. Some examples where sliding scale is used are Masters, Master
Batch Records and Releases.
Each manufacturing site and R&D function is responsible for compliance with
appropriate guideline like this.
5 Guideline
(b) Critical surfaces in the ISO 5 zone (Grade A) that are accessible during
manufacturing should be monitored with every batch in a manner that will not
increase the risk of product contamination, typically at the conclusion of the
aseptic process. Typically representative critical surfaces (filling needles,
insides stopper bowls, and stopper chutes) are monitored on a per batch basis.
(b) Microbiological
Alert and action levels should be established on the basis of system capabilities
and from historical data and should be evaluated on an ongoing basis.
6 Appendices